The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay

January 2009
Radiation Oncology;2009, Vol. 4, p61
Academic Journal
No abstract available.


Related Articles

  • Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N 1 , N 11 diethylnorspermine. Hector, Suzanne; Tummala, Ramakumar; Kisiel, Nicholas; Diegelman, Paula; Vujcic, Slavoljub; Clark, Kimberly; Fakih, Marwan; Kramer, Debora L.; Porter, Carl W.; Pendyala, Lakshmi // Cancer Chemotherapy & Pharmacology;Aug2008, Vol. 62 Issue 3, p517 

    Our previous studies showed that combined treatment of oxaliplatin and N 1 , N 11 diethyl-norspermine (DENSPM) results in massive induction of spermidine/spermine N 1 -acetyltransferase (SSAT) mRNA and activity. Since oxaliplatin and 5-fluorouracil (5FU) are used clinically in treatment of...

  • Clinical overview: adjuvant therapy of gastrointestinal cancer. Macdonald, John // Cancer Chemotherapy & Pharmacology. Supplement;Sep2004, Vol. 54, pS4 

    Adjuvant therapy has been tested widely in the treatment of cancers of the stomach, pancreas, and large bowel. In the USA, the use of postoperative chemoradiation in stomach cancer is considered a standard of care after the publication of the Intergroup Study 0116 in September 2001. This study...

  • Oxaliplatin. Simpson, Dene; Dunn, Christopher; Curran, Monique; Goa, Karen L. // Drugs;2003, Vol. 63 Issue 19, p2127 

    Oxaliplatin (Eloxatinâ„¢) is the only platinum compound to show clinical activity in colorectal cancer. The efficacy of a combination of oxaliplatin with various schedules of fluorouracil (5-FU)/folinic acid (FA) as first- or second-line treatment for advanced metastatic colorectal cancer...

  • Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells. Mori, Ryutaro; Yoshida, Kazuhiro; Tanahashi, Toshiyuki; Yawata, Kazunori; Kato, Junko; Okumura, Naoki; Tsutani, Yasuhiro; Okada, Morihito; Oue, Naohide; Yasui, Wataru // Gastric Cancer;Jul2013, Vol. 16 Issue 3, p345 

    Background: Oxaliplatin is effective against many types of cancer, and the combination of 5-fluorouracil (5FU) and oxaliplatin is synergistically effective against gastric cancer, as well as colon cancer. The FANCJ protein is one of the Fanconi anemia (FA) gene products, and its interaction with...

  • Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal, Britta K.; Davey, Mary W.; Davey, Ross A. // Cancer Chemotherapy & Pharmacology;Aug2006, Vol. 58 Issue 2, p256 

    Cisplatin produces good responses in solid tumours including small cell lung cancer (SCLC) but this is limited by the development of resistance. Oxaliplatin is reported to show activity against some cisplatin-resistant cancers but there is little known about oxaliplatin in SCLC and there are no...

  • 5-Fluorouracil Combo Promising. Prescott, Lawrence M. // Dermatology Times;Sep2003, Vol. 24 Issue 9, p56 

    Reports on the effectiveness of combination of oxaliplatin and continuous infusion of 5-flourouracil as a chemotherapeutic alternative for treating patients with squamous cell carcinoma (SCC) of the head and neck. Characterization of the association of oxaliplatin and 5-flourouracil; Evaluation...

  • Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. Allegra, Carmen J.; Yothers, Greg; O'Connell, Michael J.; Beart, Robert W.; Wozniak, Timothy F.; Pitot, Henry C.; Shields, Anthony F.; Landry, Jerome C.; Ryan, David P.; Arora, Amit; Evans, Lisa S.; Bahary, Nathan; Soori, Gamini; Eakle, Janice F.; Robertson, John M.; Moore Jr, Dennis F.; Mullane, Michael R.; Marchello, Benjamin T.; Ward, Patrick J.; Sharif, Saima // JNCI: Journal of the National Cancer Institute;Nov2015, Vol. 107 Issue 11, p1 

    Background: National Surgical Adjuvant Breast and Bowel Project R-04 was designed to determine whether the oral fluoropyrimidine capecitabine could be substituted for continuous infusion 5-FU in the curative setting of stage II/III rectal cancer during neoadjuvant radiation therapy...

  • Cetuximab in the first-line treatment of K- ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters. Ku, Geoffrey; Haaland, Benjamin; Lima Lopes, Gilberto // Cancer Chemotherapy & Pharmacology;Aug2012, Vol. 70 Issue 2, p231 

    Background: Cetuximab, a monoclonal antibody against the epidermal growth factor receptor, inconsistently improves response rates (RR), progression-free survival (PFS) and overall survival (OS) in the first-line treatment of advanced colorectal cancer patients with K- ras wild-type (WT) tumors....

  • Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Wu, Zhen-Qian; Han, Xiao-Dong; Wang, Yu; Yuan, Ke-Li; Jin, Zhi-Ming; Di, Jian-Zhong; Yan, Jun; Pan, Ye; Zhang, Pin; Huang, Xin-Yu; Wang, Zhi-Gang; Zheng, Qi // Cancer Chemotherapy & Pharmacology;Jul2011, Vol. 68 Issue 1, p87 

    Purpose: The aim of this study was to investigate the relationship between changes in IL-1β expression and intestinal apoptosis after chemotherapy. And we further determine whether interleukin-1 receptor antagonist (IL-1Ra) reduces apoptosis in vivo after 5-fluorouracil (5-FU) chemotherapy in...

  • Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy? Peng Gao; Yong-xi Song; Jing-xu Sun; Xiao-wan Chen; Ying-ying Xu; Jun-hua Zhao; Xuan-zhang Huang; Hui-mian Xu; Zhen-ning Wang // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background There is no general agreement about whether patients who have already received neoadjuvant chemoradiotherapy need further postoperative chemotherapy based on 5-fluorouracil(5-FU) or 5-FU plus oxaliplatin. Methods Medicare beneficiaries from 1992 to 2008 with Union for International...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics